Bond-based 2D TOMOCOMD-CARDD approach for drug discovery: aiding decision-making in ‘in silico’ selection of new lead tyrosinase inhibitors
Yovani Marrero‐PonceInstitut Universitari de Ciència Molecular, Universitat de València, Edifici d'Instituts de Paterna, Poligon la Coma s/n (detras de Canal Nou), Valencia, Spain. [email protected]Mahmud Tareq Hassan KhanDepartment of Pharmacology, Institute of Medical Biology, University of Tromso, Tromso, 9037, NorwayGerardo M. Casañola‐MartínDepartment of Biological Sciences, Faculty of Agricultural Sciences, University of Ciego de Avila, 69450, Ciego de Avila, CubaArjumand AtherThe Norwegian Structural Biology Centre (NorStruct), University of Tromso, Tromso, 9037, NorwayM. N. SultankhodzhaevS. Yunusov Institute of Chemistry of Plant Substances, Academy of Sciences, Uzbekistan, TashkentRamón García‐DomenechUnidad de Investigación de Diseño de Fármacos y Conectividad Molecular, Departamento de Química Física, Facultad de Farmacia, Universitat de València, Valencia, SpainFrancisco TorrensInstitut Universitari de Ciència Molecular, Universitat de València, Edifici d’Instituts de Paterna, Poligon la Coma s/n (detras de Canal Nou), P.O. Box 22085, 46071, Valencia, SpainRichard RotondoAdvanced Medisyns, Inc., 601 Carlson Parkway, Suite 1050, Minnetonka, MN, 55305, USA
ABI
Abstract
No abstract available.
Topics
Identifiers
Citations and references
Cited by 086 references
Metrics — AkademScholar · Coming soon